Naohiro Oshima

471 total citations
27 papers, 367 citations indexed

About

Naohiro Oshima is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Naohiro Oshima has authored 27 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Naohiro Oshima's work include Pharmacology and Obesity Treatment (10 papers), Natural product bioactivities and synthesis (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). Naohiro Oshima is often cited by papers focused on Pharmacology and Obesity Treatment (10 papers), Natural product bioactivities and synthesis (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). Naohiro Oshima collaborates with scholars based in Japan, Sri Lanka and Canada. Naohiro Oshima's co-authors include Fumiyuki Kiuchi, Yuji Narukawa, Noriyasu Hada, Takashi Hakamatsuka, Yukihiro Goda, Takuro Maruyama, Sumiko Hyuga, Toshihiko Hanawa, Masashi Hyuga and Yoshiaki Amakura and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Molecules and Planta Medica.

In The Last Decade

Naohiro Oshima

26 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naohiro Oshima Japan 12 151 136 122 94 75 27 367
Milan Malaník Czechia 9 206 1.4× 182 1.3× 115 0.9× 75 0.8× 52 0.7× 20 486
Chanin Sillapachaiyaporn Thailand 13 180 1.2× 171 1.3× 96 0.8× 71 0.8× 77 1.0× 26 497
Olivia R. Dale United States 13 100 0.7× 98 0.7× 150 1.2× 91 1.0× 36 0.5× 29 371
Heng‐Yuan Chang Taiwan 12 100 0.7× 154 1.1× 72 0.6× 85 0.9× 76 1.0× 19 401
Amira Mira Egypt 12 114 0.8× 110 0.8× 60 0.5× 75 0.8× 68 0.9× 25 330
Wen-Te Chang Taiwan 12 90 0.6× 165 1.2× 79 0.6× 131 1.4× 54 0.7× 15 414
Youdan Liang China 10 79 0.5× 160 1.2× 70 0.6× 77 0.8× 53 0.7× 11 417
M. Gokila Vani Taiwan 11 102 0.7× 193 1.4× 89 0.7× 63 0.7× 41 0.5× 18 511
Min Ye China 6 243 1.6× 211 1.6× 63 0.5× 133 1.4× 92 1.2× 12 465
Arief Nurrochmad Indonesia 12 72 0.5× 140 1.0× 135 1.1× 126 1.3× 69 0.9× 84 537

Countries citing papers authored by Naohiro Oshima

Since Specialization
Citations

This map shows the geographic impact of Naohiro Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiro Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiro Oshima more than expected).

Fields of papers citing papers by Naohiro Oshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohiro Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiro Oshima. The network helps show where Naohiro Oshima may publish in the future.

Co-authorship network of co-authors of Naohiro Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Naohiro Oshima. A scholar is included among the top collaborators of Naohiro Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohiro Oshima. Naohiro Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oshima, Naohiro, et al.. (2024). Scutellaria Root extract-induced hepatocytotoxicity can be controlled by regulating its baicalin content. Journal of Natural Medicines. 78(4). 978–984. 2 indexed citations
3.
Oshima, Naohiro, et al.. (2022). Elucidation of Chemical Interactions between Crude Drugs Using Quantitative Thin-Layer Chromatography Analysis. Molecules. 27(3). 593–593. 2 indexed citations
5.
Oshima, Naohiro, et al.. (2021). Analysis of Volatile Organic Compounds Emitted from Bedding Products. 4(6). 182–192.
6.
Oshima, Naohiro, et al.. (2020). Changes in the extracted amounts and seasonally variable constituents of Diospyros kaki at different growth stages. Journal of Natural Medicines. 75(1). 105–115. 7 indexed citations
7.
Yoshimura, Morio, Yoshiaki Amakura, Sumiko Hyuga, et al.. (2020). Quality Evaluation and Characterization of Fractions with Biological Activity from Ephedra Herb Extract and Ephedrine Alkaloids-Free Ephedra Herb Extract. Chemical and Pharmaceutical Bulletin. 68(2). 140–149. 16 indexed citations
8.
Hada, Noriyasu, Kimiaki Yamano, Frank Schweizer, et al.. (2019). Synthesis of the Non Reducing End Oligosaccharides of Glycosphingolipids from <i>Ascaris suum</i>. Chemical and Pharmaceutical Bulletin. 67(2). 143–154. 3 indexed citations
9.
Odaguchi, Hiroshi, Sumiko Hyuga, Hiroaki Takemoto, et al.. (2019). The Adverse Effects of Ephedra Herb and the Safety of Ephedrine Alkaloids-free Ephedra Herb Extract (EFE). YAKUGAKU ZASSHI. 139(11). 1417–1425. 14 indexed citations
10.
Oshima, Naohiro, et al.. (2018). Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production. Journal of Natural Medicines. 72(3). 706–714. 19 indexed citations
11.
Oshima, Naohiro, Nahoko Uchiyama, Sumiko Hyuga, et al.. (2018). Non-alkaloidal composition of Ephedra Herb is influenced by differences in habitats. Journal of Natural Medicines. 73(1). 303–311. 11 indexed citations
13.
Oshima, Naohiro, Takuro Maruyama, Nahoko Uchiyama, et al.. (2017). Two flavone C-glycosides as quality control markers for the manufacturing process of ephedrine alkaloids-free Ephedra Herb extract (EFE) as a crude drug preparation. Journal of Natural Medicines. 72(1). 73–79. 13 indexed citations
14.
Oshima, Naohiro, Daigo Wakana, Noriaki Kawano, et al.. (2017). Construction of Prediction Models for the Transient Receptor Potential Vanilloid Subtype 1 (TRPV1)-Stimulating Activity of Ginger and Processed Ginger Based on LC-HRMS Data and PLS Regression Analyses. Journal of Agricultural and Food Chemistry. 65(17). 3581–3588. 7 indexed citations
15.
Oshima, Naohiro, Sumiko Hyuga, Masashi Hyuga, et al.. (2016). Efficiently prepared ephedrine alkaloids-free Ephedra Herb extract: a putative marker and antiproliferative effects. Journal of Natural Medicines. 70(3). 554–562. 36 indexed citations
16.
Hyuga, Sumiko, Masashi Hyuga, Naohiro Oshima, et al.. (2016). Ephedrine alkaloids-free Ephedra Herb extract: a safer alternative to ephedra with comparable analgesic, anticancer, and anti-influenza activities. Journal of Natural Medicines. 70(3). 571–583. 65 indexed citations
17.
Oshima, Naohiro, Sayaka Masada, Ryuta Suzuki, et al.. (2016). Identification of New Diterpenes as Putative Marker Compounds Distinguishing Agnus Castus Fruit (Chaste Tree) from Shrub Chaste Tree Fruit (Viticis Fructus). Planta Medica. 82(01/02). 147–153. 11 indexed citations
18.
Oshima, Naohiro, Kazumasa Zaima, Hiroyuki Kamakura, et al.. (2014). Identification of marker compounds for Japanese Pharmacopoeia non-conforming jujube seeds from Myanmar. Journal of Natural Medicines. 69(1). 68–75. 10 indexed citations
19.
Oshima, Naohiro, Yuji Narukawa, Noriyasu Hada, & Fumiyuki Kiuchi. (2012). Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774.1. Journal of Natural Medicines. 67(2). 281–288. 25 indexed citations
20.
Oshima, Naohiro, Yuji Narukawa, Tadahiro Takeda, & Fumiyuki Kiuchi. (2012). Collagenase inhibitors from Viola yedoensis. Journal of Natural Medicines. 67(1). 240–245. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026